Annual Accounts Receivable
$160.82 M
+$5.21 M+3.35%
December 31, 2023
Summary
- As of February 7, 2025, PTCT annual accounts receivable is $160.82 million, with the most recent change of +$5.21 million (+3.35%) on December 31, 2023.
- During the last 3 years, PTCT annual accounts receivable has risen by +$90.89 million (+129.98%).
- PTCT annual accounts receivable is now at all-time high.
Performance
PTCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$199.98 M
+$12.83 M+6.85%
September 30, 2024
Summary
- As of February 7, 2025, PTCT quarterly accounts receivable is $199.98 million, with the most recent change of +$12.83 million (+6.85%) on September 30, 2024.
- Over the past year, PTCT quarterly accounts receivable has increased by +$34.26 million (+20.67%).
- PTCT quarterly accounts receivable is now -0.94% below its all-time high of $201.87 million, reached on March 31, 2023.
Performance
PTCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
PTCT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | +20.7% |
| 3 y3 years | +130.0% | +20.7% |
| 5 y5 years | +136.8% | +20.7% |
PTCT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.6% | -0.9% | +81.0% |
| 5 y | 5-year | at high | +189.6% | -0.9% | +280.0% |
| alltime | all time | at high | >+9999.0% | -0.9% | >+9999.0% |
PTC Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $199.98 M(+6.9%) |
| Jun 2024 | - | $187.15 M(-5.3%) |
| Mar 2024 | - | $197.66 M(+22.9%) |
| Dec 2023 | $160.82 M(+3.3%) | $160.82 M(-3.0%) |
| Sep 2023 | - | $165.72 M(-6.6%) |
| Jun 2023 | - | $177.50 M(-12.1%) |
| Mar 2023 | - | $201.87 M(+29.7%) |
| Dec 2022 | $155.61 M(+40.9%) | $155.61 M(+25.0%) |
| Sep 2022 | - | $124.46 M(-8.4%) |
| Jun 2022 | - | $135.94 M(-3.8%) |
| Mar 2022 | - | $141.29 M(+27.9%) |
| Dec 2021 | $110.45 M(+58.0%) | $110.45 M(+14.3%) |
| Sep 2021 | - | $96.64 M(+22.6%) |
| Jun 2021 | - | $78.80 M(-16.3%) |
| Mar 2021 | - | $94.12 M(+34.6%) |
| Dec 2020 | $69.93 M(+25.9%) | $69.93 M(+23.1%) |
| Sep 2020 | - | $56.79 M(+5.9%) |
| Jun 2020 | - | $53.64 M(+1.9%) |
| Mar 2020 | - | $52.62 M(-5.2%) |
| Dec 2019 | $55.54 M | $55.54 M(-8.0%) |
| Sep 2019 | - | $60.38 M(-21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $77.10 M(+66.4%) |
| Mar 2019 | - | $46.35 M(-31.7%) |
| Dec 2018 | $67.91 M(+68.1%) | $67.91 M(+60.9%) |
| Sep 2018 | - | $42.20 M(-28.9%) |
| Jun 2018 | - | $59.38 M(+30.2%) |
| Mar 2018 | - | $45.61 M(+12.9%) |
| Dec 2017 | $40.39 M(+62.0%) | $40.39 M(+4.3%) |
| Sep 2017 | - | $38.74 M(+14.7%) |
| Jun 2017 | - | $33.77 M(+5.0%) |
| Mar 2017 | - | $32.17 M(+29.1%) |
| Dec 2016 | $24.93 M(+124.7%) | $24.93 M(-9.0%) |
| Sep 2016 | - | $27.41 M(+38.7%) |
| Jun 2016 | - | $19.77 M(-12.6%) |
| Mar 2016 | - | $22.62 M(+103.9%) |
| Dec 2015 | $11.09 M(+149.6%) | $11.09 M(+38.4%) |
| Sep 2015 | - | $8.02 M(+56.7%) |
| Jun 2015 | - | $5.11 M(+60.9%) |
| Mar 2015 | - | $3.18 M(-28.5%) |
| Dec 2014 | $4.45 M(+364.0%) | $4.45 M(+243.0%) |
| Sep 2014 | - | $1.30 M(+35.3%) |
| Dec 2013 | $958.00 K | $958.00 K |
FAQ
- What is PTC Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for PTC Therapeutics?
- What is PTC Therapeutics annual accounts receivable year-on-year change?
- What is PTC Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for PTC Therapeutics?
- What is PTC Therapeutics quarterly accounts receivable year-on-year change?
What is PTC Therapeutics annual accounts receivable?
The current annual accounts receivable of PTCT is $160.82 M
What is the all time high annual accounts receivable for PTC Therapeutics?
PTC Therapeutics all-time high annual accounts receivable is $160.82 M
What is PTC Therapeutics annual accounts receivable year-on-year change?
Over the past year, PTCT annual accounts receivable has changed by +$5.21 M (+3.35%)
What is PTC Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of PTCT is $199.98 M
What is the all time high quarterly accounts receivable for PTC Therapeutics?
PTC Therapeutics all-time high quarterly accounts receivable is $201.87 M
What is PTC Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, PTCT quarterly accounts receivable has changed by +$34.26 M (+20.67%)